GSK reaches .2bn deal to buy food allergy biotech RAPT

GSK reaches $2.2bn deal to buy food allergy biotech RAPT

GSK has made its first major acquisition under new chief executive Luke Miels, buying US biotech…

Continue Reading
GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in .2B Deal

GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal

GSK’s presence in immunology and inflammation is heavily oriented around respiratory drugs, but the company has…

Continue Reading
Valley Health System offering allergy, immunology services

Valley Health System offering allergy, immunology services

Valley Health System is offering personalized care for children and adults facing allergies, asthma and immune-related…

Continue Reading
Peanut Allergy Treatment Aims for Durable Immune Remission

Peanut Allergy Treatment Aims for Durable Immune Remission

For families living with peanut allergy, daily life is shaped by constant vigilance—reading labels, avoiding social…

Continue Reading
The Changing Economics of Allergy Care: 2021-2025 Data Report | ModuleMD

The Changing Economics of Allergy Care: 2021-2025 Data Report | ModuleMD

GRAND BLANC, Mich., Jan. 14, 2026 /PRNewswire/ — Allergy reimbursements are falling behind inflation. Learn how top-performing…

Continue Reading
Basophil Activation Test Predicts Milk Allergy Risk

Basophil Activation Test Predicts Milk Allergy Risk

NEW FINDINGS suggest that the basophil activation test (BAT) may help identify children at highest risk…

Continue Reading